BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1384547)

  • 1. Effects of hematopoietic growth factors on chemotherapy-induced myelosuppression.
    Biesma B; Vellenga E; Willemse PH; de Vries EG
    Crit Rev Oncol Hematol; 1992 Sep; 13(2):107-34. PubMed ID: 1384547
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin in combination with other hematopoietic cytokines in attenuating chemotherapy-induced multilineage myelosuppression: brief communication.
    Vadhan-Raj S
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):16-8. PubMed ID: 8714611
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematopoietic growth factors: overview and clinical applications, Part III.
    Robinson BE; Quesenberry PJ
    Am J Med Sci; 1990 Nov; 300(5):311-21. PubMed ID: 1700606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic growth factors for the treatment of aplastic anemia.
    Kumar M; Alter BP
    Curr Opin Hematol; 1998 May; 5(3):226-34. PubMed ID: 9664165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
    St Onge J; Jacobson RJ
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant hematopoietic growth factors in bone marrow transplantation.
    Nemunaitis J
    Cancer Treat Res; 1995; 76():225-48. PubMed ID: 7577337
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical applications of haemopoietic growth factors.
    Khwaja A; Linch DC
    Leuk Lymphoma; 1992; 7 Suppl():69-72. PubMed ID: 1283549
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of hematopoietic growth factors in marrow transplantation.
    Nemunaitis J
    Curr Opin Oncol; 1994 Mar; 6(2):139-45. PubMed ID: 7516712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells.
    Herrmann F; Brugger W; Kanz L; Mertelsmann R
    Semin Oncol; 1992 Aug; 19(4):422-31. PubMed ID: 1380732
    [No Abstract]   [Full Text] [Related]  

  • 10. Hematopoietic growth factors in autologous bone marrow transplantation.
    Miller AM
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):88-95. PubMed ID: 7692607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical use of hematopoietic growth factors].
    Robak T
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical applications of hematopoietic growth factors.
    Vose JM; Armitage JO
    J Clin Oncol; 1995 Apr; 13(4):1023-35. PubMed ID: 7535842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of myelodysplastic syndromes with hemopoietic growth factors.
    Greenberg PL
    Semin Oncol; 1992 Feb; 19(1):106-14. PubMed ID: 1371018
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
    Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
    Ganser A; Hoelzer D
    Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
    [No Abstract]   [Full Text] [Related]  

  • 16. Hematopoietic growth factor therapy of myelodysplastic syndromes.
    Arcenas AG; Vadhan-Raj S
    Leuk Lymphoma; 1993; 11 Suppl 2():65-9. PubMed ID: 7510197
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of hematopoietic growth factors].
    Elonen E
    Duodecim; 1995; 111(8):733-40. PubMed ID: 8681833
    [No Abstract]   [Full Text] [Related]  

  • 18. A proposal for deciding when to prophylactically administer bone marrow (granulocyte) stimulatory factors to patients receiving cytotoxic chemotherapy.
    Markman M
    J Cancer Res Clin Oncol; 1994; 120(11):629-30. PubMed ID: 7525591
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic potential of the hematopoietic growth factors.
    Usha D; Thatte UM; Dahanukar SA
    J Postgrad Med; 1994; 40(4):210-5. PubMed ID: 9136242
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing the effectiveness of hematopoietic growth factors.
    Williams DE
    J Clin Immunol; 1994 Jul; 14(4):215-23. PubMed ID: 7523435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.